CFTR and cystic fibrosis: Soon after, several studies using viral and nonviral approaches to deliver CFTR and correct the CF defect were advanced, including an adeno-associated virus (AAV)-based vector [12], adenovirus (Ad)-based vector [13], plasmids formulated with cationic liposomes [14], and a retroviral vector [15].